Carregant...
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19
Preexisting hypertension is a known risk factor for severe COVID-19. Abnormal activation of RAS upregulates angiotensin II (Ang-II) and contributes to severe manifestations of COVID-19. Although RAS inhibitors (RASi) are a mainstay of antihypertensive therapy, they have been associated (in some anim...
Guardat en:
| Publicat a: | Med Hypotheses |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Ltd.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8114589/ https://ncbi.nlm.nih.gov/pubmed/34048987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2021.110609 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|